Vasay, Jessa Mae .
HRN: 22-20-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2026
AMPICILLIN 1GM (VIAL)
01/03/2026
01/04/2026
IVT
2g
Q6
PROM
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines